Therapeutics News

Half of a small cohort of patients with vitiligo who were treated with tofacitinib and light exposure experienced repigmentation, according to recent findings.

Encouraging safety outcomes were reported in a cohort of patients with atopic dermatitis who were treated with long-term Eucrisa.

The novel, noninvasive NASH FibroSure test may have utility in monitoring fibrosis risk in patients treated for psoriasis with methotrexate, according to recent findings.

A low-dose of naltrexone demonstrated safety and efficacy in a small cohort of patients with Hailey-Hailey disease, according to recent findings.

Study results reporting that nail findings distinguished patients with psoriatic arthritis from those with psoriasis without arthritis was among the top read articles in July on Healio.com/Dermatology.

The International Photodynamic Association announced that Pilar Acedo Nunez was awarded the 2017 IPA Early Investigator Award at the association’s world congress in Coimbra, Portugal.

Study results finding that most people incorrectly applied free sunscreen when it was provided at a state fair was among the top read articles of the past week on Healio.com/Dermatology.

The American Skin Association presented the David Martin Carter Mentor Award to Richard Edelson, MD, at the Society for Investigative Dermatology annual meeting in Portland, Oregon.

Sienna Biopharmaceuticals announced it has completed a $40 million, Series B financing to advance its diversified topical biotech pipeline.

RXi Pharmaceuticals has announced that Gerrit Dispersyn, Dr. Med Sc., has been appointed chief development officer.